Table 1.
Clinical history of patients developing kidney and urinary tract cancer.
| Patient | Birth Year | KTx Date | Tumor Type and Grade | Pathological Stage | PyVAN | Notes |
|---|---|---|---|---|---|---|
| 1M | 1952 | 2008 | 2010: Clear cell RCC FG 2 | T1a | No | 2010: Graft failure /second transplant 2010: Acute promyelocytic leukemia 2015: Death |
| 2M | 1969 | 2008 | 2010: Clear cell RCC FG 3 | T1b | No | |
| 3M | 1948 | 2003 | 2004: Clear cell RCC FG 2 | T1a | No | 2020: Death |
| 4M | 1954 | 2008 | 2008: Papillary RCC type 1 FG 2 |
T1a | No | |
| 5M | 1965 | 2005 | 2006: Clear cell RCC FG 3 | T1a | No | 2011: Acute HBV infection |
| 6F | 1969 | 2006 | 2011: Clear cell RCC FG 4 (graft) |
T3b N2 | 2007 | 2007 and 2011: CIN 2011: Graft failure |
| 7M | 1954 | 2007 | 2009: Clear cell RCC FG 2 | T3a | No | 2009: Graft failure 2010: Death |
| 8M | 1969 | 2001 | 2007: Clear cell RCC FG 2 (graft) |
T1a M1 | No | 2006: Viral enteritis |
| 9M | 1949 | 2003 | 2004: Clear cell RCC FG 2 | T1a | 2004 | 2004: Graft failure 2010: Death |
| 10M | 1942 | 2006 | 2006: Clear cell RCC FG 2 | T1a | No | 2006: Pneumonia and CMV reactivation 2006: Death |
| 11M | 1948 | 2000 | 2010: LG urothelial carcinoma |
Ta | No | 2001: CMV disease (hematological) 2002: Skin cancer and VZV reactivation 2006: Skin cancer 2007: MGUS IgG-k (plasma cells at BMB: 5%) 2014: Sepsis 2018: Death |
| 12M | 1940 | 2001 | 2001: HG In situ urothelial carcinoma |
No | 2005: Prostatic cancer (Gleason 6) 2009: Graft failure |
|
| 13M | 1954 | 2000 | 2010: LG Urothelial carcinoma |
T1 | 2001 | |
| 14M | 1947 | 2018 | 2020: HG Urothelial carcinoma |
No | ||
| 15F | 1954 | 2005 | 2020: HG Urothelial carcinoma |
T3a N2 | No | 2020: Death |
KTx: Kidney transplantation; RCC: renal cell carcinoma; FG: Fuhrmann grade; CIN: cervical intraepithelial neoplasia; PyVAN: polyomavirus-associated nephropathy; HBV: hepatitis B virus; CMV: cytomegalovirus; SCC: squamous cell carcinoma; AK: actinic keratosis; VZV: varicella zoster virus; LG: low-grade; MGUS: monoclonal gammopathy of undetermined significance; BMB: bone marrow biopsy; HG: high-grade; M: male; F: female.